A Spanish (Basque) SME with experience in ICT for the medical sector has developed a software application that allows to save the results of the COVID-19 tests in the mobile phone as well as serving as an official document for patients. The company is looking for hospitals and healthcare facilities to validate the app under a technical cooperation or license agreement.

Coronavirus disease 2019 (COVID-19) is a pandemic with a rapidly increasing incidence of infections and deaths. To help control the pandemic it is essential to have a centralized system of information on the results of public and private laboratory centres tests in real-time. Likewise, it is a key issue to ensure that the information provided by an individual to the authorities responsible for controlling mobility can be presented reliably and results are / can be guaranteed, for example at airports, at train stations, or at hospitals. 

The Spanish SME, made up of doctors and professionals from the world of communication technologies and business management, was founded in 2018 with the aim to provide solutions in the field of digitalization of medical processes. More specifically, the company’s expertise lies in the development of tools for the integral management of the medical informed consent medical procedure in digital format, which improves communication physician-patient through audiovisual technology and Blockchain security, towards a paperless health management. 

The company has developed a new system of COVID-19 passports that, based on the use of artificial intelligence techniques, allows to fine-tune the quality of the tests results and offers advantages especially in relation to mobility in transport. The system consists in a smartphone and web application that allows to store the COVID-19 test results in the mobile phone. It is an intuitive and easy-to-understand eHealth solution that guides the patient through the entire informed consent process: from explaining the procedure to the different medical consents they need to digitally sign through visual technology and animated videos.

The Covid-19 pandemic offers a context of opportunity to introduce the patients' consent in the management of their data during the triage, which is the process of determining the priority of patients' treatments by the severity of their condition or their likelihood of recovery with and without treatment. This has not been achieved yet at clinical level and therefore represents a great chance to progress in patient assistance services.
The proposed solution allows the health system and doctors to manage the different levels of patient care (follow-up from home, primary care and emergencies or hospitalization) in a much faster and more efficiently way.

Expected partners are hospitals or healthcare facilities where COVID-19 tests are performed. The company is looking for a technical cooperation or license agreement.

The company is looking for either hospitals, clinics or healthcare facilities where Covid-19 tests are run. Making use of the system proposed, results would be rapidly transferred to the company so that the technology can start functioning and be validated. The more tests are run, the better.

The Spanish SME is looking for a partner to validate the product in a field testing environment. The partner sought should be a company or institution in charge of a hospital or healthcare facility. Partners will have to perform field tests under real conditions to ensure the good work of the program. The company is looking for a technical cooperation or license agreement.

A German research institute has developed a measurement device for the calibration of smallest flow rates (<0.1 ml/min). A piston system for volumetric flow determination is set up, where a liquid with low vapor pressure can be introduced above the seal of the vertically moving piston. This new method for the calibration of gas flow meters reduces the uncertainty of the calibration. The research institute is searching for licensees.

A German research institute active in metrology has developed a measurement system for the determination of very small flow rates for the calibration of gas flow meters. For the calibration of smallest flow rates (<0.1 ml/min), a piston system for volumetric flow determination is set up, where a liquid with low vapor pressure can be introduced above the seal of the vertically moving piston.
The uncertainties usually arising from thermal input during this measuring process are minimized. An optical channel (yellow in the picture) enables the detection of leaks in the system by detecting the liquid level in two inspection windows. This new method for the calibration of gas flow meters reduces the uncertainty of the calibration.
The method uses a vertically mounted piston system to measure an unknown or generate a given flow. A liquid is fed into the annular gap between piston and housing via an inlet. This enables the automatic monitoring of the liquid for bubbles and an automatic output of a warning message via optical inspection in case of bubble detection. The thermal influences are minimized by the generation of smallest volume flows and leaks are detected by an optical measuring device. Thus, a lower measurement uncertainty is possible, especially when generating or measuring small flow rates, for example less than 1 ml per minute.
The economic aspect of the new sealing concept is the reduction of thermal influences on the calibration results. In addition, it is conceivable to use it for measuring the parasitic gas volumes that can penetrate piston seals. The described method can be used in calibration laboratories, high-precision measurements in laboratory technology as well as by manufacturers of flow measurement devices.
The research institute is searching for international licensees to increase third- party funding.

The system leads to the following advantages. 
-	Measurement of smallest flows are enabled
-	Reduction of thermal inputs
-	Detection of leaks is enabled

Patent applied in Germany

The research institute is searching for international licensees to increase third-party funding. Targeted industrial partners are calibration laboratories, manufacturers of high-precision measurement equipment for laboratory applications as well as manufacturers of flow measurement devices interested in the commercial exploitation of the technology.

A UK company based in the North of England is a leading supplier and distributor of infrared saunas for both domestic and commercial use is looking to carry out research and development through a research cooperation agreement and or a technical cooperation agreement into the sauna's capability of boosting the immune system to hopefully reduce the infection rate and help fight COVID-19 and other such respiratory infections as well an cancer and arthritis.

It is a well established belief that hot and cold therapy boosts the immune system. The most common cause of fever in the UK is a viral infection.  It has been well documented throughout history, Ancient Egyptians, Greeks and the Romans used fever therapy for its healing effects.
The most effective defense against a virus, such as the novel coronavirus, is to eliminate the risk of infection and develop a vaccine, but the former is difficult and harmful to the economy and the latter does not exist yet for COVID-19. It is therefore prudent to explore further health benefits of saunas and what role they play in boosting the immune system. Saunas create an artificial fever in the body, which kills most viruses before they take hold. Saunas are drug free, a relaxing routine and a preventative measure and this UK companies wide range of saunas provide health benefits, including respiratory conditions, arthritis and cancer relief, as well as detoxification and immune system improvements.
The company has been working on a new range of infrared saunas, producing a prototype and getting the range ready for mass production. This will be available in 3 sizes, an improved design, floating bench and a new full spectrum glass infrared heater, which emit healthy, near, mid and far infrared. The heaters can be supplied in 300w, 400w and 500w, thus allowing to increase the intensity of the infrared and air temperature in the sauna to 66.67%, this could potentially be more effective at fighting viruses. 

The advantages of infrared technology include the improvement in respiratory conditions;  Increase and improvement to the function of immune cells and improve pain relief 
Saunas are currently duty free as they are classified by SGS in Germany as Therapeutic Respiratory Devices
They also have the necessary certifcations CE(EMC,LVD); ISO9001-2000; ETL;ETS;C-TICK;ROHS,GS and SAA

They are looking for a research and development with technical experience partner to work alongside them to implement a feasibility study and explore the real health benefits of infrared saunas in the prevention of or aid to reducing the risk of virus's, It is envisaged that the partnership will take the form of a research cooperation agreement with technical expertise or a technical cooperation agreement.
This co-operation will also aid possible future UK funding options.

Organisations must be involved in immunology research or the benefits of using saunas to aid against viruses or be involved in cancer and arthritic therapy

This UK company is looking for a partner via a research co-operation agreement or a technical cooperation agreement who has the technical expertise.  This could be with a Research and Development Institution or University involved in the development of immunology research which may already be or would like to be involved in the development of the benefits that saunas have to aid viruses of any kind, in particular tackling COVID-19.  They may also be involved in research into relief of arthritis and cancer pain.

A Portuguese SME has developed a specific and innovative unit that uses sea waves energy for electricity. It can be installed in ports or jetties and be designed for the protection of coastal erosion or hydrogen production. To develop further its converter concept the SME is seeking for partners for the demonstration and improvement of the unit in a simulation environment, or interested in financial or joint venture agreement with energy sector companies to implement the first pilots in the sea.

This is a Portuguese SME with more than 15 years’ experience in civil engineering, health, safety and environment and implementation of energy efficiency solutions.
This equipment is a unit that uses the energy of sea waves and converts it in electricity. 
The unit can operate on jetties, marinas and other maritime infrastructures, taking advantage of wave energy due to the difference in height of the free surfaces of two tanks implanted in a jetty, one located on the sea side and the other on the land side using a turbine to produce electricity. The use and transformation of energy will be similar to that of tidal mills and mini hydro plants.
It works with a new concept of harnessing wave energy profiting from the kinetic energy and wave potential and using the maximum wave height. Its operation is independent of the tides.
The unit uses a mini-hydro turbine with a continuous turbine supply, independent of the wave cycle and size.
It can use existing maritime infrastructures and being a modular system, it can use one or more monoblock turbines using little space on the dock. Multiple units can work in parallel.
The electromechanical equipment is installed in a protected area and therefore there is no equipment or moving parts in direct contact with the waves.
It involves low installation costs as well as those concerning ancillary works and the ones related to connection to the electricity grid. It is possible the local use of the energy produced and the kW produced is considered green kW. In periods of higher energy production, it can be used for other purposes, namely hydrogen production and battery charging. 
The system minimizes the impact on the receiving environment, with reduced visual impact and does not contribute to any aquatic environment impact. Being a clean energy production unit it has little relevant sound impact and a positive impact on populations.
These units fight coastal erosion, allow the exploitation of aquacultures in the open sea / production of micro algae and in parallel can be used for the production of hydrogen. 
The company has all pre-testing works for the verification of the concept and resistance in extreme conditions, tested in wave channel, and is seeking to move this to a next level with self-financing partners, who could contribute to demonstration of the technology with a simulation study over a research or technical cooperation agreement. Ideal partners should have expertise in marine technology and inshore structures. The PT company also looks for investors over financial agreement and is open to form joint ventures with energy sector companies for pilot unit in the marine environment in real conditions.

Main advantages of the system:
Regarding the new concept of harnessing wave energy for electricity production
o	Optimization of the use of kinetic energy and wave potential
o	Use of the maximum wave height regardless of its height 
o	Independence of the cyclical nature of the waves
o	It uses a mini-hydro turbine
o	Continuous turbine supply (independent of the wave cycle and dimension)
o	Hydrogen production and storage system can be associated.
o	Can be designed for coastal erosion protection
o	Can be designed for aquaculture or microalgae production
•	Regarding the use of maritime infrastructure
o	Monetization of existing infrastructures
o	Using multiple units in parallel
o	Modular system, using one or more turbines
o	Monoblock turbines (creation of modular turbines), with little space on the dock
o	Electromechanical equipment installed in a protected area
o	No equipment or moving parts in direct contact with the waves

Regarding the cost of produced kW
o	Low installation costs
o	Low costs concerning ancillary works 
o	Low costs related to connection to the electricity grid once the unit will be installed in a port or jetty
o	Possibility of local use of the energy produced
o	kW produced is considered green kW

Regarding environmental impacts
o	Minimizing the impact on the receiving environment
o	Reduced visual impact
o	No impact on the aquatic environment
o	Little relevant sound impact
o	Positive impact on populations

This company is looking for industrial partners wanting to establish a joint venture agreement. The expertise of the partners should contribute to lead the product - unit that converts in electricity the sea waves energy - to the commercialization stage. Potential partners are existing players in energy industry and willing to go into wave energy business.  
Portuguese company is also looking for investors over financial agreement that can help with costs associated with developing the concept further, proving the technical feasibility and the commercial viability. The investment should cover the costs of testing and demonstration phases in sea environment. 

A Hungarian technology transfer agency offers its technology, a multi-functional medical suction device. The device is used to remove infectious material from wounds or any fluid from the patient's airway or respiratory system. The device can be used during surgery or at the patient's bed. It also provides continuous breathing and oxygenation during use. The Hungarian agency is mainly looking for license partners and investors.

A Hungarian technology broker company is offering a breakthrough technology in medical science.

Tracheostomy involves opening the area beneath the larynx, inserting into the tiny opening a properly shaped device, usually bent at right angles, and securing it to the neck in some form (often with a lumbar spine). Because the air bypasses the constriction, it provides continuous breathing and oxygenation.
The efficiency of the treatment can only be achieved by satisfying all medical needs. It is essential for clinicians to use reliable, accurate, and safe medical aspirator. Accurate medical aspirators provide controllable suction levels and improve safety requirements in hospital wards, surgical sites, pathology laboratories, dental wards, mortality, and postmortem rooms. The device is used to remove infectious material from wounds or any fluid from the patient's airway or respiratory system. The device can be used during surgery in the operating room or near patients' beds. The impact of using a mobile device (battery-operated device) on patients and their carers is invaluable. Allows safe transportation for examinations, treatments. A portable machine with the right parameters can mobilize the patient and his / her nurse and family. It provides an opportunity to break free between the four walls, to experience familiar and new places and experiences, and to maintain a healthy mental state.
The technology performs its multi-purpose tasks safely in a wider range of applications, according to practical aspects and all the needs of the user.
The easy mobility and reliability of the device and its high operating capacity in the workflow of patient care and treatment and during patient transport are essential.

All models in the model range are designed and built to perform their multi-purpose functions safely in terms of practicality and user requirements, in their most basic features, while distinguishing them from the products currently known on the market. In many ways, the models are seen as a new trend in the suction device market.

The owner of the technology intends to introduce the novel design, high technical parameters, which are not yet exploited in the market, in line with the application of several functions in a wider field of application. The technology is conquering an area of the market that is so untapped and very large.
This technology can be used and sold much more widely with the uniform applicability of several application functions, as a result of the development of its formal and technical parameters: treatment and care of acute and chronic patients, health situations, injury care, treatment of people traveling with treatment, mothers, nose and oral sucking, breast milking to feed children.
 
Main application areas:
- health care institutions,
- public, foundation, or private rehabilitation institutions.
- nursing and care institutions,
- social facilities,
- fire brigade, disaster protection, national defense.
- home - care: when treating patients, traveling, staying out of the house.

Other areas:
- hospitality, tourism,
- entertainment facilities,
- camps, campsites, beaches,
- sports facilities,
- railway stations, means of transport,

The soaring growth of the market can be attributed to the increase in health situations from home healthcare and the growing demand for compact, portable devices. Furthermore, there is an urgent need to solve the increasing incidence of chronic diseases.
The user-friendly, compact, multi-functional design offers benefits such as a point of care and eliminates the need for trained professionals to operate these devices. These benefits increase the demand for portable devices.
By increasing the capacity of the suction devices, surgical devices can also be constructed with more advantageous properties.
The agency is looking for partners who are willing to invest in the product. With a fairly strong partner, exclusive licensing can be possible.

The lifestyle impact of using a mobile machine (battery-powered device) on patients and their caregivers is invaluable. A portable machine with the right parameters can mobilize the patient and his caregiver and family. It provides an opportunity to escape the surrounding four walls, to experience familiar and new places and experiences, and to maintain a healthy mental state.

Lightweight and small size:
- Provides a quick response during treatments.
- Fits in an average bag, stroller, even carried on the shoulder and does not interfere with the free movement in spending time at home or away from home.

High operating capacity:
- When switched on, the immediate high compression safely supplies the emergency removal of any dense or firmer medium from the tracheal, nasal, and oral openings.
- In addition to the manually controlled pulsations (pump effect) when taking breast milk, the mechanical suction force by claiming all breast milk can be sucked out in any position, preventing inflammation in the breast.

The cost of manufacturing technology with premium parts is very low compared to similar devices on the market. The purchase price of competing products can be 50-60 times the production cost of this device (500-600% difference).

Four of the world's top ten deaths are from respiratory diseases, which account for 17% of all deaths. In summary, with a shrinking population, with a drastic increase in the proportion of people over sixty-five, there are hundreds of thousands of patients in need of long-term medication, care, and nursing.

Chronic Respiratory Diseases (CRD) are not curable, however, various forms of treatment that help dilate the main airways, allow free passage, and improve shortness of breath can help treat symptoms and improve the quality of life for those suffering from the disease. Often, the only solution is to implant a tracheostomy.
With the advent of the COVID 19 virus, the demand for global suction equipment has multiplied.

An important criterion in selecting component manufacturers was that they meet the standards of most manufacturers (ISO9001, EU RoHS, REACH, FDA).
After requesting quantity order quotes and samples, the company selected the most suitable quality parts.

The model meets the conditions for TÜV certification.
In the practical design and execution of the prototype, important operational aspects covering all the details were carried out according to the instructions.

The technology broker company is mainly interested in partners that are ready to use the technology.
Health care institutions, rehabilitation institutions, nursing and care institutions, social facilities, are the main target of this technology, but anyone with CRD could use this product.

The agency is looking for partners who are willing to invest in the product. With a fairly strong partner, exclusive licensing can also be a possibility.

An Italian company, young and dynamic but with solid research background, offers to public research centres, own competencies in process optimization of nanoparticles, management of new inorganic and polymeric nanoparticles, especially in their application in oncology field. 
The company is interested in research agreements, or technical cooperation agreements with research centres or companies.

The encapsulation of molecules and combination or functionalization of nanoparticles according to specific requests is sometimes hard to perform by companies or laboratories. An Italian company has developed targeted process expertise in developing innovative nanoparticles and this may lead to offer a personalized solution in order to improve the chemical-physical characteristics and pharmacokinetic properties of the molecules of interest.

The offered technology/know how includes the development of polymeric nanoparticles based on biodegradable and biocompatible polymers, that can be used as delivery carriers (synthetic or natural molecules, probes, and natural antioxidant molecules). Additionally, the nanoparticle surface can be functionalized with specific ligands (antibodies, aptamers or small organic molecules), which allow to increase the plasma half-life, reduce immunogenicity and favor the targeting towards surface proteins overexpressed on cells target. The nanoformulation improves some unfavorable chemical-physical characteristics of the encapsulated molecules: increases the solubility of poorly soluble molecules in aqueous environments; protects labile molecules from inactivation and enzymatic and chemical degradation; increases the bioavailability; increases the fraction of molecules that reaches the site of absorption or action; reduces the adverse reactions and / or unwanted side effects.
The nanoparticles can be used for drug delivery, diagnostic, cosmetics and agro-industry fields.

The company operates in the field of nanotechnologies, aimed at researchers, companies and professionals interested in the development and application of nanoparticles in building materials, pharmaceutical, biomedical, cosmetics and agro-industry areas, searching for expertise in the field of nanomaterials, and in their application to oncology.

The main activities of the Italian company are focused on:
(a) synthesis of inorganic nanomaterials including ceramic, colloidal, iron oxide, and zinc oxide nanoparticles. The surface of  nanoparticles can be functionalized with organosilicon-based derivatives, or various functional groups, for the subsequent conjugation with biomolecules, as well as contrast agents and bioactive molecules/ drugs.

(b) design and formulation of polymeric nanoparticles for passive and active “targeting, with programmable features, in order to enhance site-specificity towards different biological targets, as well as to increase the therapeutic efficacy and the bioavailability of natural and synthetic active molecules.
The nanoparticle surface can be functionalized with specific ligands (antibodies, peptides, aptamers or small organic molecules), which allow to increase the plasma half-life, reduce immunogenicity and favor the targeting toward surface proteins overexpressed on target cells.

The company may offer own expertise in the field of oncology, where they are already working. Depending on the type of expertise requested, the Italian company may offer research agreements (i.e for participation in project proposals), technical cooperation agreements or service agreements.

The nanoformulation improves some unfavorable chemical-physical characteristics of the encapsulated molecules.
Through the integration of relevant multidisciplinary approaches with medicinal chemistry and nanobiotechnology, the company can design and build nanoparticle prototypes for "Active Targeting" that ensures on heading towards different site-specific biological targets, and programmable features to increase the therapeutic efficacy and the bioavailability of active molecules.
Thanks to own expertise, the company can encapsulate molecules provided by the client and combine or functionalize the nanoparticles according to specific requests.
Moreover, it can also provide nanoparticles for the co-delivery of combination chemotherapy, that gradually becomes a desired strategy and one of the research frontiers on modern drug delivery. Nanodrug co-delivery system, which loads at least two anticancer drugs with different physicochemical and pharmacological properties into a combination delivery system, has achieved rapid development and have the potential to improve treatment response, minimize development of resistance or minimize adverse events.

The Italian company can encapsulate molecules provided by the client and engineer or functionalize the nanoparticles according to specific requests.
The company aims to support customer from the development of an idea up to the realization of a new nanoparticle prototype and its activity evaluation through:
- the structure based design of ligands for targeting
- polymer functionalization with selected ligands
- targeted nanoparticles formulation and characterization
- in vitro dissolution and stability test
- in vitro biocompatibility and biological (eg cytotoxicity) test.

The expertise of the company goes from the development of nanoparticles and up their application in oncology field where researchers may have an interest in exploiting the competency of the Italian company.

Research centres or Laboratories and or companies interested in research, or service agreements or in technical cooperation agreements.

An Italian agritech company born to satisfy sustainable farming and develop low cost releasers of water and nutrients, is looking for partners to whom to entrust research and development or physical-chemical improvements of its applications, with the aim of developing new formulations and commercial products. Researcher and high-tech & green SMEs are sought for technology and commercial agreement with technical assistance

An Italian agritech company is working to create industrial-scale production and intends to use its biodegradable and biocompatible hydrogel for applications that meet customer needs. These are composed of natural raw materials, when degraded in the soil they release strategic elements for soil fertility. These applications can absorb water, nutrients, microorganisms or other substances of interest, then release them. This technology can be useful to assist in the germination of seeds and the growth of seedlings, to convey substances and microorganisms in the environment and in the human body because they are edible and healthy. The company now proposes to proceed towards multidisciplinary collaborations with research institutes and innovative green companies with the aim of developing applications, natural carriers of microorganisms, fertilizers, protective and functional biological substances, nutrients, etc. Such collaboration could be related to technical cooperation for the development of the required applications or in a commercial agreement with technical assistance if the technologies are already available but still need to be adapted.

The patented hydrogel can be modified in its chemical and physical characteristics. Partners are sought to conduct research and development and meet specific requirements. The ideal partner with whom the Italian company intends to collaborate should: - Provide experience on natural polymers, their properties and their modifications; Abilities on synthesis, mixing and extrusion technologies in order to generate a significant improvement in the characteristics of the applications. - Capablity to  create new formulations based on predefined targets and making field tests. - Guarantee and protect the exclusivity of knowledge shared or generated by collaboration.

SMEs and researchers are sought in order to establish either a technical cooperation for the development of the required substances or a commercial agreement with technical assistance if they own technologies which are already available but they need to be adapted.

A Polish university spin-off that implements an innovative group of products constituting functional masterbatches for polymers and additives for lubricants and cutting fluids is looking for R&D partners. The innovation consists in using the properties of low-dimensional carbons in the product design process - graphene and carbon nanotubes.

The products of Polish company are intended for manufacturers of plastics, coatings, lubricants and cutting fluids. They improve their mechanical, electrical and tribological properties. The company's team consists of physicists and chemists, it cooperates with universities in the region, Poland and abroad, as well as with research institutes on the development of materials with given functionalities.

The recipes are part of the company's know-how. As progress is made, some material modifications will be reserved or licensed. At present, works on the technology of manufacturing functional masterbatches and additives to lubricants (advanced materials and tools) are being finalized. The company has additionally taken part in several projects together with other companies applying for grants for:

- Agriculture in the treatment of diseases on carriers of biodegradable plastics,

- Medical and Pharmaceutical industry,

- Engineering industry in the design of cutting fluids for machining with minimal lubrication and cooling with MQL (Minimum Quantity Lubrication).

The company's products stand out, in addition to improving or introducing new functions, access to further modifications. A specialized research staff enables solving current technological problems, performing research at every stage of production and sharing know-how in order to increase the availability of products on the market. This applies to masterbatches and lubricants.

The company sees an advantage in providing services to its customers in designing a product with the use of their substances and introducing changes in the percentage of additives on an ongoing basis in order to finally achieve the assumed goals. Constant cooperation and assistance will allow continuous monitoring and assessment of changes taking place on the market and allow several years of cooperation with various companies and independent R&D units.

The company carries out expert opinions, conducts and supervises external research projects, and cooperates with other R&D laboratories in the implementation of new products based on nanotubes and graphene with enhanced and unique properties.

The company offers 4 ranges of products:
• Functional masterbatches for the plastics, paints and varnish industry (promising market with high individualisation of production).
• Micro-carbons impregnator for operation in extreme conditions of temperature (over 2000 oC) and pressure (over 100 ATM),
• Cutting fluids for industry, including MQL. Available in the form of: emulsions, dispersions and oil. The first tests were carried out at the Rzeszów University of Technology to certify the properties of, among others, for the Aviation Valley in Poland,
• Lubricants (biodegradable) intended for the lubrication of devices with access to water, railway sleepers, agricultural machinery, drilling platforms, etc. (EU, Norway, Germany, France, Poland and others).

The company implements an innovative group of products which are functional masterbatches based on admixtures in the form of carbon nanotubes and graphene nanoflakes, which change the mechanical and electrical properties of polymers, paints and varnishes. Masterbags designed for plastics increase their mechanical strength, while masterbinders for conductive paints and varnishes, replacing copper or silver, improve electrical conductivity at very low admixture concentrations. The operation of the designed enriching additives for lubricants (level IV) is based on the use of the low-dimensional effect, i.e. the reduction of the dimensions of carbon components, graphene and nanotubes. A small amount of additive to lubricants and cutting fluids drastically reduces the coefficient of friction and improves the wear factor of the lubricated components (V). The admixtures are appreciated and are to be used in the MQL scanty lubrication technology. Standards compliance tests are ongoing (IX).

The company is looking for R&D to cooperate in such industries as: plastics, chemical, construction, printing and paints,nanotechnologies, automotive industry, aviation industry.

A Polish SME is searching for a technology of gasification and incineration of segregated waste with the aim of producing electrical and thermal energy. The company is open for any kind of cooperation with particular emphasis on commercial agreement with technical assistance.

A Polish SME – developer of proven technologies for power plants is searching a technology of gasification and incineration of segregated waste with the aim of producing electrical and thermal energy. 

The company is looking for technology in which the input materials are forest and agricultural biomass, segregated waste, plastics and  used car tyres. 

They are interested in implementing the technology on the Polish market. The electric power of the system searched cannot be more than 10 MW.

The company is looking for cooperation with research institute/university or technology transfer centre, which can offer existing technology.
Collaboration on the basis of commercial agreement with technical assistance is sought. The company is also open to any other kind of cooperation  that leads to obtaining sought technology.

- Technology of gasification and incineration of segregated waste producing electical and thermal energy.
- The electric power produced by the system searched cannot be more than 10 MW

	
- Type of partner sought: Research institute/university or technology transfer centre.

- Tasks to be performed:
Implementation of the elaborated technology, transfer of know-how, technical consultancy and trainings, joint further development, adaptation of the technology to specific needs of the Polish company.